Plant pectin: A potential source for cancer suppression

American Journal of Pharmacology and Toxicology

Volumn 8, Issue 1, 2013, Pages 9-19

  Niture, Suryakant K ^a   Refai, Lubna ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer prevention; Citrus pectin; Modified citrus pectin

Indexed keywords

ANTINEOPLASTIC AGENT; BORTEZOMIB; CALCIUM PECTINATE BEAD; CYCLOOXYGENASE 2; DEXAMETHASONE; DRUG CARRIER; GALECTIN 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MODIFIED CITRUS PECTIN; PECTIN; RESVERATROL; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANGIOSARCOMA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CHELATION THERAPY; DIARRHEA; DRUG ABSORPTION; DRUG DETOXIFICATION; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG STRUCTURE; HUMAN; INTESTINE INFECTION; LIVER CANCER; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MELANOMA; MERCURIALISM; METASTASIS; MOLECULAR INTERACTION; MYELOID LEUKEMIA; MYELOMA; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKIN CANCER; TUMOR INVASION; UNSPECIFIED SIDE EFFECT;

CITRUS;

EID: 84876836931     PISSN: 15574962     EISSN: 15574970     Source Type: Journal    
DOI: 10.3844/ajptsp.2013.9.19     Document Type: Review

References (63)

1. Baldwin, J.L. and A.C. Shah, 1993. Pectin-induced occupational asthma. Chest, 104: 1936-1937. DOI: 10.1378/chest.104.6.1936b
2. Boyd, D.R. and S.J. Genuis, 2008. The environmental burden of disease in Canada: Respiratory disease, cardiovascular disease, cancer and congenital affliction. Environ. Res., 106: 240-249. DOI: 10.1016/j.envres.2007.08.009.
3. Bresalier, R.S., P.S. Yan, J.C. Byrd, R. Lotan and A. Raz, 1997. Expression of the endogenous galactosebinding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer, 80: 776-787. DOI: 10.1002/(SICI)1097-0142(19970815)80:4<776::AIDCNCR17> 3.0.CO;2-Q
4. Brunekreef, B. and S.T. Holgate, 2002. Air pollution and health. Lancet, 360: 1233-1242. DOI: 10.1016/S0140-6736(02)11274-8.
5. Chauhan, D., G. Li, K. Podar, T. Hideshima and P. Neri et al., 2005. A novel carbohydratebased therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells. Cancer Res., 65: 8350-8358. DOI: 10.1158/0008-5472.CAN-05-0163.
6. Chen, C.H., M.T. Sheu, T.F. Chen, Y.C. Wang and W.C. Hou et al., 2006. Suppression of endotoxin-induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways. Biochem. Pharmacol., 72: 1001-1009. DOI: 10.1016/j.bcp.2006.07.001.
7. Cheng, H., S. Li, Y. Fan, X. Gao and M. Hao et al., 2011. Comparative studies of the antiproliferative effects of ginseng polysaccharides on HT-29 human colon cancer cells. Med. Oncol., 28: 175-181. DOI: 10.1007/s12032-010-9449-8.
8. Cohen, A.J., M.S. Forse and S.M. Tarlo, 1993. Occupational asthma caused by pectin inhalation during the manufacture of jam. Chest, 103: 309-311. DOI: 10.1378/chest.103.1.309.
9. Daas, P.J., B. Boxma, A.M. Hopman, A.G. Voragen and H.A. Schols, 2001. Nonesterified galacturonic acid sequence homology of pectins. Biopolymers, 58: 1-8. DOI: 10.1002/1097-0282(200101)58:1<1::AIDBIP10> 3.0.CO;2-I
10. Das, S. and K.Y. Ng, 2010. Resveratrol-loaded calciumpectinate beads: Effects of formulation parameters on drug release and bead characteristics. J. Pharm. Sci., 99: 840-860. DOI: 10.1002/jps.21880.
11. Dumic, J., S. Dabelic and M. Flogel, 2006. Galectin-3: An open-ended story. Biochim. Biophys. Acta., 1760: 616-635. DOI: 10.1016/j.bbagen.2005.12.020.
12. Eliaz, I., A.T. Hotchkiss, M.L. Fishman and D. Rode, 2006. The effect of modified citrus pectin on urinary excretion of toxic elements. Phytother. Res., 20: 859-864. DOI: 10.1002/ptr.1953.
13. Eliaz, I., E. Weil and B. Wilk, 2007. Integrative medicine and the role of modified citrus pectin/aliginates in heavy metal chelation and detoxification-five case reports. Forsch Komplementmed, 14: 358-364. DOI: 10.1159/000109829.
14. Fisher, H., W.G. Siller and P. Griminger, 1966. The retardation by pectin of cholesterol-induced atherosclerosis in the fowl. J. Atherosclerosis Res., 6: 292-298. DOI: 10.1016/S0368-1319(66)80012-1.
15. Fujioka, S., J. Niu, C. Schmidt, G.M. Sclabas and B. Peng et al., 2004. NF-kappaB and AP-1 connection: Mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol. Cell. Biol., 24: 7806-7819. PMID: 15314185.
16. Fukumori, T., N. Oka, Y. Takenaka, P. Nangia-Makker and E. Elsamman et al., 2006. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer. Cancer Res., 66: 3114-3119. DOI: 10.1158/0008-5472.CAN-05-3750.
17. Glinskii, O.V., V.H. Huxley, G.V. Glinksy, K.J. Pienta and A. Raz et al., 2005. Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia, 7: 522-527. DOI: 10.1593/neo.04646.
18. Glinsky, V.V. and A. Raz, 2009. Modified citrus pectin anti-metastatic properties: One bullet, multiple targets. Carbohydr. Res., 344: 1788-1791. DOI: 10.1016/j.carres.2008.08.038.
19. Guess, B.W., M.C. Scholz, S.B. Strum, R.Y. Lam and H.J. Johnson et al., 2003. Modified Citrus Pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: A phase II pilot study. Prostate Cancer Prostatic Dis., 6: 301-304. DOI: 10.1038/sj.pcan.4500679.
20. Gunning, A.P., R.J. Bongaerts and V.J. Morris, 2009. Recognition of galactan components of pectin by galectin-3. FASEB J., 23: 415-424. DOI: 10.1096/fj.08-106617.
21. Hayashi, A., A.C. Gillen and J.R. Lott, 2000. Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in Balb-c mice. Altern. Med. Rev., 5: 546-552. PMID: 11134977.
22. Hsieh, T.C. and J.M. Wu, 1995. Changes in cell growth, cyclin/kinase, endogenous phosphoproteins and 23 nm gene expression in human prostatic JCA-1 cells treated with modified citrus pectin. Biochem. Mol. Biol. Int., 37: 833-841. PMID: 8624488.
23. Inohara, H and A. Raz, 1994. Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj J., 11: 527-532. DOI: 10.1007/BF00731303.
24. Jackson, C.L., T.M. Dreaden, L.K. Theobald, N.M. Tran and T.L. Beal et al., 2007. Pectin induces apoptosis in human prostate cancer cells: Correlation of apoptotic function with pectin structure. Glycobiology, 17: 805-819. DOI: 10.1093/glycob/cwm054.
25. Jackson, S.P. and J. Bartek, 2009. The DNA-damage response in human biology and disease. Nature, 461: 1071-1078. DOI: 10.1038/nature08467.
26. Jemal, A., R. Siegel, J. Xu and E. Ward, 2010. Cancer statistics. CA Cancer J. Clin., 60: 277-300. DOI: 10.3322/caac.20073.
27. Jenkins, D.J, A.R. Leeds, M.A. Gassal, B. Cochet and G.M. Alberti, 1977. Decrease in postprandial insulin and glucose concentrations by guar and pectin. Ann. Intern. Med., 86: 20-23. PMID: 835924.
28. Jenkins, D.J., A.C. Newton, A.R. Leeds and J.H. Cummings, 1975. Effect of pectin, guar gum and wheat fiber on serum cholesterol. Lancet, 1: 116-117. PMID: 49474.
29. Jew, S., S.S. AbuMweis and P.J.H. Jones, 2009. Evolution of the human diet: Linking our ancestral diet to modern functional foods as a means of chronic disease prevention. J. Med. Food, 12: 925-934. DOI: 10.1089/jmf.2008.0268.
30. Johnson, K.D., O.V. Glinskii, V.V. Mossine, J.R. Turk and T.P. Mawhinney et al., 2007. Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. Neoplasia, 9: 662-670. DOI: 10.1593/neo.07433.
31. Joye, D.D. and G.A. Luzio, 2000. Process for selective extraction of pectins from plant material by differential pH. Carbohydr. Polym., 43: 337-342. DOI: 10.1016/S0144-8617(00)00191-0.
32. Kiyohara, H., M. Hirano, X.G. Wen, T. Matsumoto and X.B. Sun et al., 1994. Characterization of an antiulcer pectic polysaccharide from leaves of Panax ginseng C.A. Meyer. Carbohydr. Res., 263: 89-101. DOI: 10.1016/0008-6215(94)00151-0.
33. Krall, S.M. and R.F. Mcfeeters, 1998. Pectin hydrolysis: Effect of temperature, degree of methylation, pH and calcium on hydrolysis rates. J. Agric. Food Chem., 46: 1311-1315. DOI: 10.1021/jf970473y
34. Krzeslak, A. and A. Lipinska, 2004. Galectin-3 as a multifunctional protein. Cell. Mol. Biol. Lett., 9: 305-328. PMID: 15213811.
35. Kushi, L.H., T. Byers, C. Doyle, E.V. Bandera and M. McCullough et al., 2006. American cancer society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J. Clin., 56: 254-281. DOI: 10.3322/canjclin.56.5.254.
36. Landrigan, P.J., C.B. Schechter, J.M. Lipton, M.C. Fahs and J. Schwartz, 2002. Environmental pollutants and disease in American children: Estimates of morbidity, mortality and costs for lead poisoning, asthma, cancer and developmental disabilities. Environ. Health Perspec., 110: 721-728. DOI: 10.1289/ehp.02110721.
37. Liu, H.Y., Z.L. Huang, G.H. Yang, W.Q. Lu and N.R. Yu, 2008. Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. World J. Gastroenterol., 14: 7386-7391. DOI: 10.3748/wjg.14.7386.
38. May, C.D., 1990. Industrial pectins: Sources, production and applications. Carbohydr. Polym., 12: 79-99. DOI: 10.1016/0144-8617(90)90105-2.
39. Nangia-Makker, P., V. Hogan, Y. Honjo, S. Baccarini and L. Tait et al., 2002. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J. Natl. Cancer Inst., 94: 1854-1862. DOI: 10.1093/jnci/94.24.1854.
40. Nicholas, J., 2009. Fighting cancer metastasis and heavy metal toxicities with modified citrus pectin. Life Extens. Mag.
41. Niture, S.K., 2008. Comparative biochemical and structural characterizations of fungal polygalacturonases. Biol.: Cellu. Mol. Biol., 63: 1-19. DOI: 10.2478/s11756-008-0018-y
42. Olano-Martin, E., G.H. Rimbach, G.R. Gibson and R.A. Rastall, 2003. Pectin and pecticoligosaccharides induce apoptosis in vitro human colonic adenocarcinoma cells. Anticancer Res., 23: 341-346. PMID: 12680234.
43. Olano-Martin, E., G.R. Gibson and R.A. Rastell, 2002. Comparison of the in vitro bifidogenic properties of pectins and pectic-oligosaccharides. J. Applied Microbiol., 93: 505-511. DOI: 10.1046/j.1365-2672.2002.01719.x
44. Perez-Padilla, R., A. Schilmann and H. Riojas-Rodriguez, 2010. Respiratory health effects of indoor air pollution. Int. J. Tuberc. Lung Dis., 14: 1079-1086. PMID: 20819250.
45. Pienta, K.J., H. Naik, A. Akhtar, K. Yamazaki and T.S. Replogle et al., 1995. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J. Natl. Cancer Inst., 87: 348-353. DOI: 10.1093/jnci/87.5.348.
46. Platt, D. and A. Raz, 1992. Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J. Natl. Cancer Inst., 84: 438-442. DOI: 10.1093/jnci/84.6.438.
47. Rabbani, G.H., T. Teka, B. Zaman, N. Majid and M. Khatun et al., 2001. Clinical studies in persistent diarrhea: Dietary management with green banana or pectin in Bangladeshi children. Gastroenterology, 121: 554-560. DOI: 10.1053/gast.2001.27178.
48. Ramachandran, C., B.J. Wilk, A. Hotchkiss, H. Chau and I. Eliaz et al., 2011. Activation of human Thelper/ inducer cell, T-cytotoxic cell, B-cell and Natural Killer (NK)-Cells and induction of Natural killer cell activity against K562 chronic myeloid leukemia cells with modified citrus pectin. BMC Complement Altern. Med., 11: 59-59. DOI: 10.1186/1472-6882-11-59.
49. Ridley, B.L., M.A. O'Neill and D. Mohnen, 2001. Pectins: Structure, biosynthesis and oligogalacturonide-related signaling. Phytochemistry, 57: 929-967. DOI: 10.1016/S0031-9422(01)00113-3.
50. Rinaldo, M., 1996. Physicochemical properties of pectins in solution and in gel sates. Progress Biotechnol., 14: 21-33. DOI: 10.1016/S0921-0423(96)80243-7.
51. Sankpal, U., H. Pius, M. Khan, M. Shukoor and P. Maliakal et al., 2012. Environmental factors in causing human cancers: Emphasis on tumorigenesis. Tumor Biol., 33: 1265-1274. DOI: 10.1007/s13277-012-0413-4.
52. Sathisha, U.V., S. Jayaram, M.A.H. Nayaka and S.M. Dharmesh, 2007. Inhibition of galectin-3 mediated cellular interactions by pectic polysaccharides from dietary sources. Glycoconj J., 24: 497-507. DOI: 10.1007/s10719-007-9042-3.
53. Srivastava, P. and R. Malviya, 2011. Sources of pectin, extraction and its applications in pharmaceutical industry-An overview. Indian J. Natural Product Resources, 2: 10-18.
54. Triplehorn, C. and P.S. Millard, 2002. A rice-based diet with green banana or pectin reduced diarrhea in infants better than a rice-alone diet. ACP J. Club., 136: 67-67. PMID: 11874292.
55. Veldman, F.J., C.H. Nair, H.H. Vorster, W.J. Vermaak and J.C. Jerling et al., 1999. Possible mechanisms through which dietary pectin influences fibrin network architecture in hypercholesterolaemic subjects. Thromb. Res., 93: 253-264. DOI: 10.1016/S0049-3848(98)00170-4.
56. Vincken, J.P., H.A. Schols, R.J. Oomen, M.C. McCann and P. Ulvskov et al., 2003. If homogalacturonan were a side chain of rhamnogalacturonan I. Implications for cell wall architecture. Plant Physiol., 132: 1781-1789. DOI: 10.1104/pp.103.022350.
57. Voragen, A.G.J., W. Pilnik, J.F. Thibault, M.A.V. Axelos and C.M.G.C. Renard, 2010. Pectins. In: Food Polysaccharides and their Applications, Stephen A.M. and G.O. Phillips (Eds.), Taylor and Francis, Boca Raton, FL., ISBN-10: 0824759222, pp: 287-339.
58. Watanabe, K., T. Kawamori, S. Nakatsugi and K. Wakabayashi, 2000. COX-2 and iNOS, good targets for chemoprevention of colon cancer. Biofactors, 12: 129-133. PMID: 11216473.
59. Willats, W.G., L. McCartney, W. Mackie and J.P. Knox, 2001. Pectin: Cell biology and prospects for functional analysis. Plant Mol. Biol., 47: 9-27. DOI: 10.1023/A:1010662911148.
60. Wong, C.K., K.N. Leung and K.P. Fung, 1994. Immunomodulatory and anti-tumor polysaccharides from medicinal plants. J. Int. Med. Res., 22: 299-312. PMID: 7895893.
61. Yan, J. and A.E. Katz, 2010. PectaSol-C modified citrus pectin induces apoptosis and inhibition of proliferation in human and mouse androgendependent and-independent prostate cancer cells. Integr. Cancer Ther., 9: 197-203. DOI: 10.1177/1534735410369672.
62. Yu, F., R.L. Finley, A. Raz and H.R. Kim, 2002. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J. Biol. Chem., 277: 15819-15827. DOI: 10.1074/jbc.M200154200.
63. Zhao, Z.Y., L. Liang, X. Fan, Z. Yu and A.T. Hotchkiss et al., 2008. The role of modified citrus pectin as an effective chelator of lead in children hospitalized with toxic lead levels. Altern. Ther. Health Med., 14: 34-38. PMID: 18616067